Evogene Ltd.
EVGNNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $4.88M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.35$1.49
- Volume (live)
- -
- Avg. volume (3M)
- 2.56M
Evogene (EVGN) Stock Price & Financial Analysis
Evogene Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.38 - $0.41 |
|---|---|
| 52-Week High | $1.49 |
| 52-Week Low | $0.35 |
| Open | $0.41 |
| Volume (last close) | 37.67K |
| Average Volume (3M) | 2.56M |
| Revenue (TTM) | 1.31M |
|---|---|
| Net Income (TTM) | -9.07M |
| Free Cash Flow (TTM) | -11.44M |
| EPS (TTM) | −$0.92 |
| Profit Margin | -694.19% |
| Operating Margin | -1044.30% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 4.88M |
|---|---|
| Shares Outstanding | 12.20M |
| Price to Sales (P/S) | 3.73 |
| Price to Book (P/B) | -1.48 |
| EV/EBITDA | 0.20 |
| 50-Day MA | $0.51 |
|---|---|
| 200-Day MA | $0.71 |
| 1-Year Change | −68.01% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Evogene at a Glance
As of the Oct 16, 2026 close, Evogene (EVGN) has a market capitalization of $4.88M. The stock trades at 3.7× sales. Over the trailing twelve months it lost $9.07M on revenue of $1.31M and burned $11.44M of free cash flow. Revenue fell 79.5% year over year.
As of its latest reported balance sheet, it holds $9.32M in cash and securities against $2.10M of debt, a net cash position of $7.21M.
Evogene does not currently pay a dividend.
The share price is down 68.0% over the past year. At $0.39 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.35 to $1.49, below its 200-day moving average of $0.71.
Frequently Asked Questions About Evogene
What is the current stock price for EVGN?
As of the Oct 16, 2026 close, EVGN stock trades at $0.39. The 52-week range is $0.35–$1.49, with a day range of $0.38–$0.41.
What is the P/E ratio for EVGN?
The P/E ratio (Price-to-Earnings) for EVGN is shown in the Key Statistics section. This valuation metric helps compare Evogene Ltd. to industry peers.
Does EVGN pay dividends?
Evogene does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EVGN?
Analyst ratings and recommendations for EVGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of EVGN?
As of the Oct 16, 2026 close, Evogene's market capitalization is $4.7M, classifying it as a micro-cap company. Evogene operates in the Healthcare sector within the Biotechnology industry.